Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Douglas A. McIntyre | Dec 10, 2006 at 11:30 AM EST

Biotech & Medical Venture Deals Roundup

From BioHealth Investor by Adam Rubenstein NeoVista, Inc. (Fremont, CA), an ophthalmic device company focused on the treatment of age-related…

Douglas A. McIntyre | Dec 8, 2006 at 4:10 AM EST

Vanda Schizophrenia Drug Meets Phase III Endpoint

From BioHealth Investor by H.S. AyoubBioHealthInvestor.com Shares of Vanda Pharmaceuticals (VNDA) look to open much higher on Thursday as the…

Douglas A. McIntyre | Dec 8, 2006 at 4:07 AM EST

Thursday’s Top Biotech and Medical Stocks

From BioHealth Investor by Mark S. Senak As the lame duck Senate gets ready to waddle off to their place…

Douglas A. McIntyre | Dec 7, 2006 at 3:06 PM EST

Stent Safety Issues at the FDA….Hogwash

Stock Tickers: BSX, JNJ, ANPI, SRDX, CONR, BMY, SNY, ABT, MDT The FDA review of stents should not change the…

Douglas A. McIntyre | Dec 7, 2006 at 10:14 AM EST

Boston Scientific Goes To The Mattresses

Stocks: (MRK)(BSX)(JNJ)(PFE) Yet another investigation of the health affect of stents. Where will it end? The FDA is bringing in…

Douglas A. McIntyre | Dec 7, 2006 at 3:57 AM EST

Halozyme Signs Deal with Roche, Continues to Impress

From BioHealth Investor I recommended Halozyme Therapeutics (HTI) in August (and mentioned it again last week that I was holding…

Douglas A. McIntyre | Dec 6, 2006 at 12:56 PM EST

Let’s Hope They Told Pfizer (PFE)

Comscore has released data that say that 33 million people researched presciption medications on the internet in Q3. That is…

Douglas A. McIntyre | Dec 6, 2006 at 12:56 PM EST

Let’s Hope They Told Pfizer (PFE)

Comscore has released data that say that 33 million people researched presciption medications on the internet in Q3. That is…

Douglas A. McIntyre | Dec 6, 2006 at 8:45 AM EST

Merck Putting Vioxx Behind It (MRK)(PFE)

Vioxx lawsuit could drag on for years, even a decade. But, Merck is looking ahead. It confirmed 2006 guidance and…

Douglas A. McIntyre | Dec 6, 2006 at 4:31 AM EST

Biotech Landmark Study Finds Challenges to Industry

From BioHealth Investor BayBio, Northern California’a leading biotechnology industry organization, published its landmark study BayBio: IMPATCT 2007. What does Northern…

Douglas A. McIntyre | Dec 6, 2006 at 4:27 AM EST

Searching for Values in the Drug Stock Universe

By Chad Brand of Peridot Capitalist Not too long ago I wrote about pharmaceutical giant Pfizer (PFE) and how it…

Douglas A. McIntyre | Dec 5, 2006 at 6:11 PM EST

Cramer Has a Stent Trade

On tonight’s MAD MONEY show on CNBC, Cramer reviewed what the state of the stent market will be. There is…

Douglas A. McIntyre | Dec 5, 2006 at 8:50 AM EST

Gambling Drug Fails Trials; Somaxon Shares Lower

Somaxon Pharmaceuticals (SOMX-NASDAQ) has announced essentially failed results from the company’s Phase 2/3 clinical trial evaluating 20 mg and 40…

Douglas A. McIntyre | Dec 5, 2006 at 4:24 AM EST

Pfizer Setback Disappointing, Not Catastrophic

By Chad Brand of Peridot Capitalist I was actually planning a broader pharmaceutical post , but in light of the…

Douglas A. McIntyre | Dec 5, 2006 at 4:15 AM EST

Onyx Pharma Tumbles As Skin Cancer Drug Fails Phase III

From BioHealth Investor Shares of Onyx Pharmaceuticals (ONXX) dropped more than 30% on Monday after the company announced at a…

1 … 389 390 391 392

Health and Healthcare Articles

All Health and Healthcare Articles

Biotech & Medical Venture Deals Roundup

Vanda Schizophrenia Drug Meets Phase III Endpoint

Thursday’s Top Biotech and Medical Stocks

Stent Safety Issues at the FDA….Hogwash

Boston Scientific Goes To The Mattresses

Halozyme Signs Deal with Roche, Continues to Impress

Let’s Hope They Told Pfizer (PFE)

Let’s Hope They Told Pfizer (PFE)

Merck Putting Vioxx Behind It (MRK)(PFE)

Biotech Landmark Study Finds Challenges to Industry

Searching for Values in the Drug Stock Universe

Cramer Has a Stent Trade

Gambling Drug Fails Trials; Somaxon Shares Lower

Pfizer Setback Disappointing, Not Catastrophic

Onyx Pharma Tumbles As Skin Cancer Drug Fails Phase III

Gold Went Flat in 2026. This Award-Winning Fund Still Milks 13% Income Out of It

Married 9 Years? One More Anniversary Changes What Social Security Owes You Forever

How a 58-Year-Old Couple Built an $11,000 Monthly Paycheck Around DGRO, SPYI, and VYM

Married 9 Years? One More Anniversary Changes What Social Security Owes You Forever

How a 58-Year-Old Couple Built an $11,000 Monthly Paycheck Around DGRO, SPYI, and VYM

Gold Went Flat in 2026. This Award-Winning Fund Still Milks 13% Income Out of It

Married 9 Years? One More Anniversary Changes What Social Security Owes You Forever

Health and Healthcare Articles

All Health and Healthcare Articles

Biotech & Medical Venture Deals Roundup

Vanda Schizophrenia Drug Meets Phase III Endpoint

Thursday’s Top Biotech and Medical Stocks

Stent Safety Issues at the FDA….Hogwash

Boston Scientific Goes To The Mattresses

Halozyme Signs Deal with Roche, Continues to Impress

Let’s Hope They Told Pfizer (PFE)

Let’s Hope They Told Pfizer (PFE)

Merck Putting Vioxx Behind It (MRK)(PFE)

Biotech Landmark Study Finds Challenges to Industry

Searching for Values in the Drug Stock Universe

Cramer Has a Stent Trade

Gambling Drug Fails Trials; Somaxon Shares Lower

Pfizer Setback Disappointing, Not Catastrophic

Onyx Pharma Tumbles As Skin Cancer Drug Fails Phase III

Gold Went Flat in 2026. This Award-Winning Fund Still Milks 13% Income Out of It

Married 9 Years? One More Anniversary Changes What Social Security Owes You Forever

How a 58-Year-Old Couple Built an $11,000 Monthly Paycheck Around DGRO, SPYI, and VYM

Featured Reads

Married 9 Years? One More Anniversary Changes What Social Security Owes You Forever

How a 58-Year-Old Couple Built an $11,000 Monthly Paycheck Around DGRO, SPYI, and VYM